(2S,3R,4R,5R)-1-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]hexane-2,3,4,5-tetrol

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (2S,3R,4R,5R)-1-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]hexane-2,3,4,5-tetrol
• 化学式: C₂₁H₂₇ClO₅
• 分子量: 394.9
• InChiKey: UYPFVEWDSSGFOH-JTMTTYTKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  27
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  90.2
• 氢给体数：
  4
• 氢受体数：
  5

文献信息

• PHENYL C-GLUCOSIDE DERIVATIVE CONTAINING DEOXYGLUCOSE STRUCTURE, PREPARATION METHOD AND USE THEREOF
  申请人：Tianjin Institute Of Pharmaceutical Research

  公开号：EP2933250A1

  公开（公告）日：2015-10-21

  The present invention provides a phenyl C-glucoside derivative containing a deoxyglucose structure as represented by formula I, preparation method thereof, a pharmaceutical composition comprising the same, and uses thereof in the preparation of medicaments for treating diabetes, wherein substituents R1-R7 are as defined in the specification. The present invention also provides a method for synthesizing the phenyl C-glucoside derivative containing a deoxyglucose structure and an intermediate product. The method has advantages of being simple to manage and of low cost, which is suitable for large-scale industrial production. The present invention further provides a cocrystal of (1S)-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-1,6-dideoxy-D-glucose and L-proline, and preparation method and uses thereof.

  本发明提供一种含有脱氧葡萄糖结构的苯基C-葡萄糖苷衍生物，其表示为式I，其制备方法，包含其的制药组合物以及在制备治疗糖尿病药物方面的用途，其中取代基R1-R7如规范中所定义。本发明还提供一种合成含有脱氧葡萄糖结构的苯基C-葡萄糖苷衍生物和中间产物的方法。该方法具有管理简单和低成本的优点，适用于大规模工业生产。本发明还提供了（1S）-1-[4-氯-3-(4-乙氧基苯基)苯基]-1,6-二脱氧-D-葡萄糖和L-脯氨酸的共晶体，其制备方法和用途。
• PHENYL C-GLUCOSIDE DERIVATIVE CONTAINING DEOXYGLUCOSE STRUCTURE, PREPARATION METHOD AND USES THEREOF
  申请人：Tianjin Institute Of Pharmaceutical Research

  公开号：EP3246324A3

  公开（公告）日：2018-01-10

  The present invention provides a phenyl C-glucoside derivative containing a deoxyglucose structure as represented by formula I, preparation method thereof, a pharmaceutical composition comprising the same, and uses thereof in the preparation of medicaments for treating diabetes, wherein substituents R1-R7 are as defined in the specification. The present invention also provides a method for synthesizing the phenyl C-glucoside derivative containing a deoxyglucose structure and an intermediate product. The method has advantages of being simple to manage and of low cost, which is suitable for large-scale industrial production. The present invention further provides a cocrystal of (1S)-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-1,6-dideoxy-D-glucose and L-proline, and preparation method and uses thereof.

  本发明提供了一种由式I表示的含有脱氧葡萄糖结构的苯基C-葡萄糖苷衍生物、其制备方法、包含其的药物组合物以及其在制备治疗糖尿病药物中的用途，其中取代基R1-R7如说明书中所定义。本发明还提供了一种合成含有脱氧葡萄糖结构的苯基 C-葡萄糖苷衍生物和中间产物的方法。该方法具有操作简单、成本低的优点，适合大规模工业化生产。本发明进一步提供了一种(1S)-1-[4-氯-3-(4-乙氧基苄基)苯基]-1,6-二脱氧-D-葡萄糖和 L-脯氨酸的共晶体及其制备方法和用途。
• Phenyl c-glucoside derivative containing deoxyglucose structure, preparation method and use thereof
  申请人：Tianjin Institute of Pharmaceutical Research

  公开号：US10294259B2

  公开（公告）日：2019-05-21

  The present invention provides a phenyl C-glucoside derivative containing a deoxyglucose structure as represented by formula I, preparation method thereof, a pharmaceutical composition comprising the same, and uses thereof in the preparation of medicaments for treating diabetes, wherein substituents R1-R7 are as defined in the specification. The present invention also provides a method for synthesizing the phenyl C-glucoside derivative containing a deoxyglucose structure and an intermediate product. The method has advantages of being simple to manage and of low cost, which is suitable for large-scale industrial production. The present invention further provides a cocrystal of (1S)-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-1,6-dideoxy-D-glucose and L-proline, and preparation method and uses thereof.

  本发明提供了一种由式I表示的含有脱氧葡萄糖结构的苯基C-葡萄糖苷衍生物、其制备方法、包含其的药物组合物以及其在制备治疗糖尿病药物中的用途，其中取代基R1-R7如说明书中所定义。本发明还提供了一种合成含有脱氧葡萄糖结构的苯基 C-葡萄糖苷衍生物和中间产物的方法。该方法具有操作简单、成本低的优点，适合大规模工业化生产。本发明进一步提供了一种(1S)-1-[4-氯-3-(4-乙氧基苄基)苯基]-1,6-二脱氧-D-葡萄糖和 L-脯氨酸的共晶体及其制备方法和用途。
• [EN] CRYSTAL FORM A OF (1S)-1-[4-CHLORO-3-(4-ETHOXYBENZYL)PHENYL]-1,6-DIDEOXY-D-GLUCOSE AND PREPARATION METHOD AND USE THEREOF<br/>[FR] FORME CRISTALLINE A DE (1S)-1-[4-CHLORO-3-(4-ÉTHOXYBENZYL)PHÉNYL]-1,6-DIDÉSOXY-D-GLUCOSE ET PROCÉDÉ DE PRÉPARATION ET UTILISATION DE CELLE-CI
  申请人：TIANJIN INST PHARM RESEARCH

  公开号：WO2014139447A1

  公开（公告）日：2014-09-18

  本发明提供了一种（1S）-1-［4-氯-3-（4-乙氧基苄基）苯基］-1,6-二脱氧-D-葡萄糖的晶型A，其特征在于，以2θ角度表示的X-射线粉末衍射在3.56、5.42、10.84、13.58、16.28、17.00、18.48、19.74、21.72、22.52、22.96、28.32、29.58附近处具有衍射峰。还提供了该晶型A的制备方法，其在用于制备治疗糖尿病的药物组合物中的应用，以及含有该晶型的药物组合物。
• EP2933250B1
  申请人：——

  公开号：EP2933250B1

  公开（公告）日：2017-08-09